LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | +64.3% | 391 | +105.8% | 0.00% | – |
| Q2 2023 | $14 | +7.7% | 190 | +3.8% | 0.00% | – |
| Q1 2023 | $13 | +8.3% | 183 | +4.0% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 176 | +10.7% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 159 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 159 | +59.0% | 0.00% | – |
| Q1 2022 | $11,000 | -47.6% | 100 | -24.8% | 0.00% | – |
| Q4 2021 | $21,000 | – | 133 | +6550.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 2 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |